Mir122 (microRNA 122) - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Gene: Mir122 (microRNA 122) Rattus norvegicus
Analyze
Symbol: Mir122
Name: microRNA 122
RGD ID: 2325577
Description: Predicted to act upstream of or within several processes, including BMP signaling pathway; erythrocyte differentiation; and multicellular organismal-level iron ion homeostasis. Predicted to be located in extracellular exosome. Predicted to be part of RISC complex. Biomarker of pterygium. Human ortholog(s) of this gene implicated in hepatocellular carcinoma. Orthologous to human MIR122 (microRNA 122); INTERACTS WITH (-)-epigallocatechin 3-gallate; 1-naphthyl isothiocyanate; aflatoxin B1.
Type: ncrna
RefSeq Status: PROVISIONAL
Previously known as: rno-mir-122
RGD Orthologs
Human
Mouse
Dog
Pig
Alliance Genes
More Info more info ...
Latest Assembly: mRatBN7.2 - mRatBN7.2 Assembly
Position:
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCr81861,028,817 - 61,028,901 (+)NCBIGRCr8
mRatBN7.21858,758,703 - 58,758,787 (+)NCBImRatBN7.2mRatBN7.2
UTH_Rnor_SHR_Utx1860,852,801 - 60,852,885 (+)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.01861,551,154 - 61,551,238 (+)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.01859,375,977 - 59,376,061 (+)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.01860,755,285 - 60,755,369 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_5.01859,956,811 - 59,956,895 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
Celera1856,889,469 - 56,889,553 (+)NCBICelera
Cytogenetic Map18q12.1NCBI
JBrowse: View Region in Genome Browser (JBrowse)
Model


Gene-Chemical Interaction Annotations     Click to see Annotation Detail View
(+)-catechin  (ISO)
(+/-)-Aegeline  (ISO)
(-)-citrinin  (ISO)
(-)-epigallocatechin 3-gallate  (EXP,ISO)
(RS)-coclaurine  (ISO)
(RS)-norcoclaurine  (ISO)
(S)-coclaurine  (ISO)
1,2-dichloroethane  (ISO)
1,3,5-trinitro-1,3,5-triazinane  (ISO)
1-naphthyl isothiocyanate  (EXP)
2,3,7,8-tetrachlorodibenzodioxine  (ISO)
3-hydroxybenzoic acid  (ISO)
3-hydroxyphenylacetic acid  (ISO)
3-methylcholanthrene  (ISO)
5-aza-2'-deoxycytidine  (ISO)
aflatoxin B1  (EXP,ISO)
allyl alcohol  (EXP)
androstane  (ISO)
arsane  (ISO)
arsenic atom  (ISO)
arsenite(3-)  (ISO)
arsenous acid  (ISO)
atrazine  (EXP)
azoxystrobin  (EXP)
benzene  (ISO)
benzo[a]pyrene  (ISO)
bifenthrin  (ISO)
bisphenol A  (EXP,ISO)
butyric acid  (ISO)
cadmium atom  (EXP)
cadmium dichloride  (EXP)
caffeine  (ISO)
carbon nanotube  (ISO)
chlorpyrifos  (EXP)
choline  (ISO)
cisplatin  (EXP)
clofibrate  (EXP)
crocin-1  (EXP,ISO)
diarsenic trioxide  (ISO)
diclofenac  (EXP,ISO)
Diosbulbin B  (ISO)
doxorubicin  (EXP)
ethanol  (EXP,ISO)
folic acid  (ISO)
formaldehyde  (ISO)
furan  (EXP)
gallic acid  (EXP,ISO)
gentamycin  (EXP)
glyphosate  (EXP)
hydrogen peroxide  (ISO)
hydroquinone  (ISO)
idelalisib  (ISO)
imidacloprid  (EXP)
isoprenaline  (EXP)
L-methionine  (ISO)
LY294002  (EXP,ISO)
marinobufagenin  (EXP)
methamidophos  (ISO)
methanol  (ISO)
methapyrilene  (EXP,ISO)
monocrotaline  (ISO)
N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal  (ISO)
ochratoxin A  (ISO)
oleanolic acid  (ISO)
paracetamol  (EXP,ISO)
paraquat  (ISO)
phenobarbital  (EXP,ISO)
procyanidin B2  (EXP,ISO)
progesterone  (ISO)
puromycin  (EXP)
resveratrol  (EXP,ISO)
rotenone  (EXP)
sirolimus  (EXP)
testosterone  (ISO)
tetrachloromethane  (EXP,ISO)
thiabendazole  (EXP)
toluene  (ISO)
tolvaptan  (ISO)
troglitazone  (ISO)
vanillic acid  (ISO)
xanthone  (EXP)
yohimbine  (ISO)

Gene Ontology Annotations     Click to see Annotation Detail View

Cellular Component

References

References - curated
# Reference Title Reference Citation
1. Hepatitis B virus X protein mediated suppression of miRNA-122 expression enhances hepatoblastoma cell proliferation through cyclin G1-p53 axis. Bandopadhyay M, etal., Infect Agent Cancer. 2016 Aug 15;11:40. doi: 10.1186/s13027-016-0085-6. eCollection 2016.
2. Regulation of Apoptosis by miR-122 in Pterygium via Targeting Bcl-w. Cui YH, etal., Invest Ophthalmol Vis Sci. 2016 Jul 1;57(8):3723-30. doi: 10.1167/iovs.16-19402.
3. Differential miRNA Expression in the Liver of Balb/c Mice Protected by Vaccination during Crisis of Plasmodium chabaudi Blood-Stage Malaria. Dkhil MA, etal., Front Microbiol. 2017 Jan 11;7:2155. doi: 10.3389/fmicb.2016.02155. eCollection 2016.
4. Micro-RNA-122 levels in acute liver failure and chronic hepatitis C. Dubin PH, etal., J Med Virol. 2014 Sep;86(9):1507-14. doi: 10.1002/jmv.23987. Epub 2014 Jun 4.
5. MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells. Fornari F, etal., Cancer Res. 2009 Jul 15;69(14):5761-7. doi: 10.1158/0008-5472.CAN-08-4797. Epub 2009 Jul 7.
6. Alcohol facilitates HCV RNA replication via up-regulation of miR-122 expression and inhibition of cyclin G1 in human hepatoma cells. Hou W, etal., Alcohol Clin Exp Res. 2013 Apr;37(4):599-608. doi: 10.1111/acer.12005. Epub 2012 Nov 5.
7. MicroRNA sponge blocks the tumor-suppressing functions of microRNA-122 in human hepatoma and osteosarcoma cells. Ma J, etal., Oncol Rep. 2014 Dec;32(6):2744-52. doi: 10.3892/or.2014.3517. Epub 2014 Sep 25.
8. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
9. MicroRNA 122, Regulated by GRLH2, Protects Livers of Mice and Patients From Ethanol-Induced Liver Disease. Satishchandran A, etal., Gastroenterology. 2018 Jan;154(1):238-252.e7. doi: 10.1053/j.gastro.2017.09.022. Epub 2017 Oct 4.
10. Circulating liver-specific miR-122 as a novel potential biomarker for diagnosis of cholestatic liver injury. Shifeng H, etal., PLoS One. 2013 Sep 27;8(9):e73133. doi: 10.1371/journal.pone.0073133. eCollection 2013.
11. Loss of microRNA 122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G(1) -modulated P53 activity. Wang S, etal., Hepatology. 2012 Mar;55(3):730-41. doi: 10.1002/hep.24809.
12. Circulating MicroRNA-122 Is Associated With the Risk of New-Onset Metabolic Syndrome and Type 2 Diabetes. Willeit P, etal., Diabetes. 2017 Feb;66(2):347-357. doi: 10.2337/db16-0731. Epub 2016 Nov 29.
13. Decreased expression of hepatocyte nuclear factor 4α (Hnf4α)/microRNA-122 (miR-122) axis in hepatitis B virus-associated hepatocellular carcinoma enhances potential oncogenic GALNT10 protein activity. Wu Q, etal., J Biol Chem. 2015 Jan 9;290(2):1170-85. doi: 10.1074/jbc.M114.601203. Epub 2014 Nov 24.
14. Oleanolic acid suppresses the proliferation of lung carcinoma cells by miR-122/Cyclin G1/MEF2D axis. Zhao X, etal., Mol Cell Biochem. 2015 Feb;400(1-2):1-7. doi: 10.1007/s11010-014-2228-7. Epub 2014 Dec 4.
Additional References at PubMed
PMID:16381832   PMID:17604727   PMID:19520079   PMID:20403161   PMID:20548288   PMID:21364282   PMID:23185045   PMID:23922812   PMID:24205035   PMID:25769350   PMID:25954995   PMID:25958847  
PMID:26125464   PMID:26130369   PMID:27569279   PMID:27940300   PMID:28751928   PMID:29579170   PMID:30030064   PMID:30318957   PMID:30925002   PMID:31373075   PMID:31468622   PMID:31543343  
PMID:31626960   PMID:31630081   PMID:31887421   PMID:32061171   PMID:32315718   PMID:33161100   PMID:33247804   PMID:33428882   PMID:33460628   PMID:33950267   PMID:34002676   PMID:34235595  
PMID:34998813   PMID:35133561   PMID:35170385   PMID:35174434   PMID:35563621   PMID:36584755   PMID:37024064   PMID:37529835   PMID:38115999  


Genomics

Comparative Map Data
Mir122
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCr81861,028,817 - 61,028,901 (+)NCBIGRCr8
mRatBN7.21858,758,703 - 58,758,787 (+)NCBImRatBN7.2mRatBN7.2
UTH_Rnor_SHR_Utx1860,852,801 - 60,852,885 (+)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.01861,551,154 - 61,551,238 (+)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.01859,375,977 - 59,376,061 (+)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.01860,755,285 - 60,755,369 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_5.01859,956,811 - 59,956,895 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
Celera1856,889,469 - 56,889,553 (+)NCBICelera
Cytogenetic Map18q12.1NCBI
MIR122
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh381858,451,074 - 58,451,158 (+)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl1858,451,074 - 58,451,158 (+)EnsemblGRCh38hg38GRCh38
GRCh371856,118,306 - 56,118,390 (+)NCBIGRCh37GRCh37hg19GRCh37
Build 361854,269,285 - 54,269,369 (+)NCBINCBI36Build 36hg18NCBI36
Celera1852,834,313 - 52,834,397 (+)NCBICelera
Cytogenetic Map18q21.31NCBI
HuRef1852,826,687 - 52,826,771 (+)NCBIHuRef
CHM1_11856,113,488 - 56,113,572 (+)NCBICHM1_1
T2T-CHM13v2.01858,651,794 - 58,651,878 (+)NCBIT2T-CHM13v2.0
Mir122
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCm391865,381,932 - 65,381,997 (+)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl1865,381,932 - 65,381,997 (+)EnsemblGRCm39 Ensembl
GRCm381865,248,861 - 65,248,926 (+)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl1865,248,861 - 65,248,926 (+)EnsemblGRCm38mm10GRCm38
MGSCv371865,408,515 - 65,408,580 (+)NCBIGRCm37MGSCv37mm9NCBIm37
Celera1866,524,341 - 66,524,406 (+)NCBICelera
Cytogenetic Map18E1NCBI
MIR122
(Canis lupus familiaris - dog)
Dog AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
CanFam3.1117,593,858 - 17,593,915 (-)NCBICanFam3.1CanFam3.1canFam3CanFam3.1
CanFam3.1 Ensembl117,593,837 - 17,593,929 (-)EnsemblCanFam3.1canFam3CanFam3.1
Dog10K_Boxer_Tasha118,577,763 - 18,577,820 (-)NCBIDog10K_Boxer_Tasha
ROS_Cfam_1.0117,474,133 - 17,474,190 (-)NCBIROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl117,474,112 - 17,474,204 (-)EnsemblROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.1117,532,433 - 17,532,490 (-)NCBIUMICH_Zoey_3.1
UNSW_CanFamBas_1.0117,430,446 - 17,430,503 (-)NCBIUNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0117,698,572 - 17,698,629 (-)NCBIUU_Cfam_GSD_1.0
MIR122
(Sus scrofa - pig)
Pig AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Sscrofa11.1 Ensembl1162,329,767 - 162,329,860 (-)EnsemblSscrofa11.1susScr11Sscrofa11.1
Sscrofa11.11162,329,776 - 162,329,860 (-)NCBISscrofa11.1Sscrofa11.1susScr11Sscrofa11.1
Sscrofa10.21179,916,336 - 179,916,420 (-)NCBISscrofa10.2Sscrofa10.2susScr3

miRNA Target Status

Predicted Targets
Summary Value
Count of predictions:15500
Count of gene targets:7715
Count of transcripts:8274
Interacting mature miRNAs:rno-miR-122-3p, rno-miR-122-5p
Prediction methods:Microtar, Miranda, Pita, Rnahybrid, Targetscan
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.


QTLs in Region (mRatBN7.2)
The following QTLs overlap with this region.    Full Report CSV TAB Printer Gviewer
RGD IDSymbolNameLODP ValueTraitSub TraitChrStartStopSpecies
2299160Iddm35Insulin dependent diabetes mellitus QTL 352.79blood glucose amount (VT:0000188)age at onset/diagnosis of type 1 diabetes mellitus (CMO:0001140)18420794160377792Rat
2293708Bss46Bone structure and strength QTL 468.80.0001lumbar vertebra morphology trait (VT:0010494)lumbar vertebra cortical cross-sectional area (CMO:0001690)181179151863636873Rat
1578661Bss20Bone structure and strength QTL 203.7femur morphology trait (VT:0000559)femoral neck cross-sectional area (CMO:0001697)181179151883218561Rat
1578667Bss21Bone structure and strength QTL 213.5femur morphology trait (VT:0000559)femoral neck cortical cross-sectional area (CMO:0001702)181179151883218561Rat
1358358Sradr6Stress Responsive Adrenal Weight QTL 62.49adrenal gland mass (VT:0010420)both adrenal glands wet weight (CMO:0000164)181194429959330563Rat
6903359Bp355Blood pressure QTL 3553.6arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)181194454459796478Rat
2313082Bss85Bone structure and strength QTL 850.80.0001long bone metaphysis morphology trait (VT:0000133)tibia midshaft total cross-sectional area (CMO:0001715)181495133759951337Rat
1358193Emca2Estrogen-induced mammary cancer QTL 21.6mammary gland integrity trait (VT:0010552)post-insult time to mammary tumor formation (CMO:0000345)181800759963571040Rat
1600373Mamtr6Mammary tumor resistance QTL 6mammary gland integrity trait (VT:0010552)mammary tumor number (CMO:0000343)181927890183218561Rat
1331741Bp232Blood pressure QTL 2323.59112arterial blood pressure trait (VT:2000000)diastolic blood pressure (CMO:0000005)182137289383213037Rat
1331733Bp233Blood pressure QTL 2333.97196arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)182479697779788953Rat
2325839Bp348Blood pressure QTL 3480.001arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)182557098570570985Rat
2293704Bss35Bone structure and strength QTL 354.590.0002femur strength trait (VT:0010010)femur midshaft polar moment of inertia (CMO:0001669)182896485373964853Rat
2300157Bmd66Bone mineral density QTL 6613.10.0001lumbar vertebra mineral mass (VT:0010511)volumetric bone mineral density (CMO:0001553)182896485373964853Rat
2300177Bmd65Bone mineral density QTL 6519.70.0001femur mineral mass (VT:0010011)volumetric bone mineral density (CMO:0001553)182896485373964853Rat
9589816Gluco68Glucose level QTL 687.250.001blood glucose amount (VT:0000188)plasma glucose level (CMO:0000042)182979296574792965Rat
8694378Bw157Body weight QTL 1573.590.001body lean mass (VT:0010483)lean tissue morphological measurement (CMO:0002184)182979296574792965Rat
9590318Scort22Serum corticosterone level QTL 227.640.001blood corticosterone amount (VT:0005345)plasma corticosterone level (CMO:0001173)182979296574792965Rat
1331754Bp230Blood pressure QTL 2304.61609arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)182979296574792965Rat
738005Anxrr11Anxiety related response QTL 113.4exploratory behavior trait (VT:0010471)number of entries into a discrete space in an experimental apparatus (CMO:0000960)183003981375039813Rat
61383Bp47Blood pressure QTL 4717.3arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)183127168160377755Rat
1331742Bp228Blood pressure QTL 2283.88752arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)183135940859796643Rat
1331774Bp226Blood pressure QTL 2264.41065arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)183135940859796643Rat
1331776Bp225Blood pressure QTL 2252.829arterial blood pressure trait (VT:2000000)diastolic blood pressure (CMO:0000005)183135940859796643Rat
1331798Bp224Blood pressure QTL 2243.53873arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)183135940859796643Rat
1331727Bp237Blood pressure QTL 2373.053arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)183135940861698465Rat
61429Cia17Collagen induced arthritis QTL 174.6joint integrity trait (VT:0010548)joint inflammation composite score (CMO:0000919)183135940870263868Rat
2303120Mamtr8Mammary tumor resistance QTL 80.001mammary gland integrity trait (VT:0010552)mammary tumor growth rate (CMO:0000344)183135940883218561Rat
6903347Bp350Blood pressure QTL 3504.4arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)183135953059796478Rat
631274Sprol1Serum protein level QTL 15.3blood total protein amount (VT:0005567)serum total protein level (CMO:0000661)183139332077209694Rat
631518Bw11Body weight QTL 112.8body mass (VT:0001259)body weight (CMO:0000012)183587072380870723Rat
61367Iddm4Insulin dependent diabetes mellitus QTL 42.330.0074blood glucose amount (VT:0000188)plasma glucose level (CMO:0000042)183819245583192455Rat
1598826Anxrr20Anxiety related response QTL 203.04body movement coordination trait (VT:0005424)number of rearing movements in an experimental apparatus (CMO:0001752)184143297183828827Rat
6893683Bw110Body weight QTL 1102.70.002body mass (VT:0001259)body weight (CMO:0000012)184334502283828827Rat
8694366Abfw8Abdominal fat weight QTL 86.380.001visceral adipose mass (VT:0010063)abdominal fat pad weight to body weight ratio (CMO:0000095)184664067583828827Rat
8694432Bw165Body weight QTL 1653.810.001body lean mass (VT:0010483)lean tissue morphological measurement (CMO:0002184)184664067583828827Rat
9589041Epfw12Epididymal fat weight QTL 1217.080.001epididymal fat pad mass (VT:0010421)epididymal fat pad weight to body weight ratio (CMO:0000658)184664067583828827Rat
1331736Bp227Blood pressure QTL 2272.791arterial blood pressure trait (VT:2000000)diastolic blood pressure (CMO:0000005)184671876359796643Rat
1331780Bp238Blood pressure QTL 2383.269arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)184671876359796643Rat
6903345Bp349Blood pressure QTL 3493.9arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)184671893559796478Rat
6903349Bp351Blood pressure QTL 3513.5arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)184671893559796478Rat
6903351Bp352Blood pressure QTL 3523.3arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)184671893559796478Rat
61360EaeyExperimental allergic encephalomyelitis QTL y3nervous system integrity trait (VT:0010566)experimental autoimmune encephalomyelitis duration (CMO:0001424)184698893960377753Rat
2303571Bw92Body weight QTL 923body mass (VT:0001259)body weight (CMO:0000012)184852004483828827Rat
2303584Gluco55Glucose level QTL 552blood glucose amount (VT:0000188)blood glucose level (CMO:0000046)184852004483828827Rat
7411719Strs5Sensitivity to stroke QTL 59.4cerebrum integrity trait (VT:0010549)percentage of study population developing cerebrovascular lesions during a period of time (CMO:0000932)184999995865845095Rat
2293658Bmd23Bone mineral density QTL 237.30.0001femur mineral mass (VT:0010011)total volumetric bone mineral density (CMO:0001728)185146473363636873Rat
738008Hcar14Hepatocarcinoma resistance QTL 144.3liver integrity trait (VT:0010547)liver nonremodeling tumorous lesion number (CMO:0001462)185146473383218561Rat
1331730Scl27Serum cholesterol level QTL 273.826blood HDL cholesterol amount (VT:0000184)serum high density lipoprotein cholesterol level (CMO:0000361)185229287559796643Rat
1331752Bw27Body weight QTL 272.963body mass (VT:0001259)body weight (CMO:0000012)185229287565845095Rat
1359020Ppulsi2Prepulse inhibition QTL 22.71prepulse inhibition trait (VT:0003088)acoustic startle response measurement (CMO:0001519)185229287573997283Rat
1600375Mcs22Mammary carcinoma susceptibility QTL 223.3mammary gland integrity trait (VT:0010552)mammary tumor growth rate (CMO:0000344)185253976363933058Rat
631509Sald2Serum aldosterone level QTL 22.9blood aldosterone amount (VT:0005346)serum aldosterone level (CMO:0000487)185253976369140759Rat
12880368Bw187Body weight QTL 1870.045body mass (VT:0001259)body weight (CMO:0000012)185253976376104388Rat
12904067Cm122Cardiac mass QTL 1220.001heart mass (VT:0007028)heart wet weight to body weight ratio (CMO:0002408)185253976376104388Rat
12904069Cm123Cardiac mass QTL 1230.001heart left ventricle mass (VT:0007031)heart left ventricle weight to body weight ratio (CMO:0000530)185253976376104388Rat
12904070Cm124Cardiac mass QTL 1240.01heart right ventricle mass (VT:0007033)heart right ventricle weight to body weight ratio (CMO:0000914)185253976376104388Rat
12904071Am18Aortic mass QTL 180.001aorta mass (VT:0002845)aorta weight to aorta length to body weight ratio (CMO:0002722)185253976376104388Rat
12904073Kidm71Kidney mass QTL 710.001kidney mass (VT:0002707)both kidneys wet weight to body weight ratio (CMO:0000340)185253976376104388Rat
2301417Bp319Blood pressure QTL 3190.002arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)185253976376104388Rat
1300125Rf26Renal function QTL 263.2urine potassium amount (VT:0010539)urine potassium excretion rate (CMO:0000761)185253986365844950Rat
1298072Cia26Collagen induced arthritis QTL 263.6joint integrity trait (VT:0010548)joint inflammation composite score (CMO:0000919)185470976983828827Rat


Expression


Sequence

Nucleotide Sequences
RefSeq Transcripts NR_031864 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
GenBank Nucleotide JAXUCZ010000018 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles

RefSeq Acc Id: NR_031864
RefSeq Status: PROVISIONAL
Type: NON-CODING
Position:
Rat AssemblyChrPosition (strand)Source
GRCr81861,028,817 - 61,028,901 (+)NCBI
mRatBN7.21858,758,703 - 58,758,787 (+)NCBI
Rnor_6.01860,755,285 - 60,755,369 (+)NCBI
Rnor_5.01859,956,811 - 59,956,895 (+)NCBI
Celera1856,889,469 - 56,889,553 (+)NCBI
Sequence:

Additional Information

Database Acc Id Source(s)
AGR Gene RGD:2325577 AgrOrtholog
BioCyc Gene G2FUF-7231 BioCyc
miRBase MI0000891 ENTREZGENE
NCBI Gene 100314023 ENTREZGENE
PhenoGen Mir122 PhenoGen
RNAcentral URS00003380CC RNACentral
  URS000075CD37 RNACentral
  URS000075D321 RNACentral


Nomenclature History
Date Current Symbol Current Name Previous Symbol Previous Name Description Reference Status
2015-04-09 Mir122  microRNA 122  Mir122  microRNA mir-122  Name updated 61478 APPROVED
2010-06-02 Mir122  microRNA mir-122      Symbol and Name status set to provisional 70820 PROVISIONAL